DrugPatentWatch Database Preview
Patent: 9,358,232
» See Plans and Pricing
Summary for Patent: 9,358,232
Title: | Methods for treating cancer using TOR kinase inhibitor combination therapy |
Abstract: | Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phen- yl)acrylamide to a patient having a cancer. |
Inventor(s): | Hege; Kristen Mae (Burlingame, CA), Chopra; Rajesh (Summit, NJ) |
Assignee: | Signal Pharmaceuticals, LLC (San Diego, CA) |
Application Number: | 14/254,010 |
Patent Claims: | see list of patent claims |
Details for Patent 9,358,232
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | Signal Pharmaceuticals, LLC (San Diego, CA) | 2033-04-17 | RX | Orphan | search |
Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | Signal Pharmaceuticals, LLC (San Diego, CA) | 2033-04-17 | RX | Orphan | search |
Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 002 | 1997-11-26 | Start Trial | Signal Pharmaceuticals, LLC (San Diego, CA) | 2033-04-17 | RX | search | |
Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | Signal Pharmaceuticals, LLC (San Diego, CA) | 2033-04-17 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,358,232
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2014172430 | Start Trial |
United States of America | 2014314751 | Start Trial |
Taiwan | 201521725 | Start Trial |
Mexico | 2015014455 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |